InvestorsHub Logo
Followers 6685
Posts 22551
Boards Moderated 2
Alias Born 06/27/2006

Re: None

Thursday, 11/01/2018 12:02:53 PM

Thursday, November 01, 2018 12:02:53 PM

Post# of 343860
GRDO--Points to consider:

George Sharp with his tremendous reputation and business acumen related to OTC companies, has taken over the GRDO shell and is in the process of expeditiously cleaning up the filings, books and corporate share structure. The alacrity with which he has already accomplished many of these things is a positive harbinger of what lies just ahead. So here is what we are ostensibly looking at:

Powerful and knowledgeable CEO.
No toxic debt
No dilution
Reductions in outstanding shares
No reverse split

In addition to the aforementioned, Mr. Sharp has indicated that he will be bringing his company into the GRDO shell. (CLIPPER HOLDINGS CORPORATION). This merger will allow Mr. Sharp to expand his business model, through extensive knowledge he has attained, not least of which was working with the SEC and FINRA as an extension of his advisory position with OTC Markets. This intrinsic knowledge puts Mr. Sharp, and through his direct control as CEO, GRDO, in the driver's seat for assisting other OTC companies with corporate triage and access to financial markets, that would otherwise be inaccessible to these embryonic companies. It was first accomplished with RDGL, and now GRDO will become the publicly traded entity by which all future transactions shall funnel through.

So how does GRDO go about procuring consistent revenue streams, (making money)? This is quite genius and elementary at the same time. By assisting other companies, two types of revenues will be generated:

1) Corporate triage. (companies will pay GRDO for assistance and guidance in resolving their past delinquencies, getting current, reducing the share structure and public image).

2) After the aforementioned is accomplished, then comes the ability of the GRDO corporate management team, led by Mr. Sharp, with his vast connections and business savvy, to line up financing options that allow companies to procure their much needed capital to fund growth and inventory, while not utilizing convertible debentures which have long been the bane of these markets.

I shall explain further. With RDGL, Mr. Sharp identified a need of much needed capital to fund RDGL's research and development. the share price of that equity was going down every day, as the debt converters were only interested in their own self gain, and cared not for the company, nor its' share holders. There was no way that the price would recover without multiple reverse splits. That is where Mr. Sharp came in. He immediately got a standstill agreement implemented, which allowed the company to quickly regain the share price, thus putting their management in a MUCH better position to negotiate future funding.

Extrapolating this business model to the thousands of possible clients throughout the OTC, well one can see how genius this business plan will be, and HOW PROFITABLE it will be for GRDO share holders. Traditionally companies have ended up paying 10 x 20 times more, via shares, and then share price declines, to receive such funds. Due to the closing of the loopholes with Alpine and COR, there was no realistic way for debt converters to clear shares, thus there was no incentive for them to give any monies to these companies. With Mr. Sharp's business model, all debt will be tied to preferred shares, with specific, farther out, exercisable options. Companies will now have time to develop and hone their business plan, while giving them the share price and equity to enhance these efforts.

How couldn't this be a WIN/WIN?

SPORTYNORTY